Jeffrey I.D. Lewis & Kristin M. Whidby

  

Jeffrey I.D. Lewis is a partner at Fried, Frank, Harris, Shriver & Jacobson LLP, resident in the firm’s New York office. A chemical engineer and registered patent attorney, Mr. Lewis represents both plaintiffs and defendants in a range of technology-related sectors but focuses primarily on pharmaceuticals, chemicals, biotechnology and life sciences. He is a past President of the American Intellectual Property Law Association (AIPLA) and a fellow of both AIPLA and the American Bar Foundation. Mr. Lewis has appeared as Counsel of Record amicus curiae in numerous cases before the Supreme Court of the United States and other courts, and was Counsel of Record AIPLA in Akamai v. Limelight both before the Supreme Court this week before the Federal Circuit.

Kristin M. Whidby is a litigation associate and registered patent attorney at Fried, Frank, Harris, Shriver & Jacobson LLP, resident in the firm’s Washington, D.C. office. Ms. Whidby's practice is concentrated in the field of intellectual property, including the drafting of patent opinions, providing pre-litigation counseling, and engaging in patent litigation. She has extensive experience in litigating matters relating to nuclear and mechanical technologies, as well as the chemical, pharmaceutical and biotechnological fields. Ms. Whidby has assisted in several trials concerning intellectual property issues, including a recent international arbitration concerning a patent related to night vision technology, a U.S. District Court trial concerning a patent related to coding of digital data, and a U.S. District Court trial over the validity of a patent related to contact lens materials. She has also represented clients in patent-related disputes before the Patent Trial and Appeals Board, Virginia state court, the U.S. Court of Appeals for the Federal Circuit, and the U.S. Supreme Court.

Recent Articles by

AIPLA supports en banc rehearing in Akamai v. Limelight on single entity infringement rule

There can be little doubt of the exceptional importance of Akamai Technologies, Inc. v. Limelight Networks, Inc. to the intellectual property community, and to innovators as a whole. The issue of joint infringement has been the focus of much discussion in recent years by academia, the media, and industry. In its 2014 remand of this case, the Supreme Court suggested this Court would have the opportunity to “revisit the § 271(a) question if it so chooses,” 134 S. Ct. 2111, 2120 (“Akamai III”). The AIPLA, as amicus curiae, argues that the Federal Circuit should choose to do so by rehearing the case en banc because the single entity rule as set out by the Panel majority would make it nearly impossible for certain patent holders to enforce their patents against joint infringers.